Astellas e AviadoBio anunciam acordo de licença exclusiva para terapia genética FTD-GRN

Text: Astellas and AviadoBio Announce Exclusive License Agreement for FTD-GRN Gene Therapy. Background: A male and female research meet with a guest, with the male shaking their hand.

Astellas Pharma and AviadoBio have announced an exclusive license agreement for AVB-101, an experimental gene therapy for FTD-GRN currently undergoing a phase 1/2 clinical trial in the United States and Europe. FTD caused by an inherited GRN genetic mutation inhibits the production of the essential protein progranulin, which leads to the accumulation of proteins such…

consulte Mais informação

Atualização de voluntários: comemorando o crescimento da conscientização sobre a DFT

Text: Volunteer Update - Celebrating the Growth of FTD Awareness Background: Melissa Fisher, Scott Rose, and attendees of their celebration gather for a group photo.

It is not often that the community comes together in person, so it was extra special when AFTD Ambassadors Melissa Fisher and Scott Rose organized a gathering in Portland to celebrate the new Oregon state awareness proclamation. The proclamation establishing September 22-29, 2024, as FTD Awareness Week was signed by Governor Tina Kotek on August…

consulte Mais informação

Avançando a esperança – AFTD participa da conferência da Sociedade Internacional para FTD de 2024

Text: Advancing Hope - AFTD Attends 2024 International Society for FTD Conference Background: AFTD senior staff and members of the Board at the ISFTD 2024 conference, posing for a photo at AFTD's booth.

The AFTD was proud to have ten staff members, and four Board members attend the International Society for FTD Conference (ISFTD) in Amsterdam in late September. This is a premier bi-annual conference convening approximately 800 leading experts in FTD – including researchers, clinicians, drug developers, advocates, and people with lived experience. The AFTD Programs team…

consulte Mais informação

Conferência anual de cuidadores do Penn FTD Center de 2024: nutrindo nossos cuidadores

Graphic: Nurturing Our Caregivers: Tools for Navigating FTD. A Conference Focused on YOU! November 18, 2024

AFTD staff will be hosting an informational table at the Penn FTD Center’s 2024 Caregiver Conference, titled Nurturing Our Caregivers, being held Monday, November 18, 2024 from 8:30 AM – 3:30 PM. The conference is an opportunity for people diagnosed with FTD, their care partners, family, and friends to learn more about FTD and the resources…

consulte Mais informação

Estudo descobre que FTD e ALS têm características celulares e moleculares semelhantes

Text: Study Finds That FTD and ALS Have Similar Cellular and Molecular Characteristics Background: Scientist working on genetic research on a PC

Um estudo realizado por pesquisadores do MIT e da Mayo Clinic publicado no periódico Cell descobriu que a DFT e a ELA têm características celulares e moleculares notavelmente semelhantes, apesar de suas diferenças clínicas. A descoberta de 2011 de que a mutação do gene C9orf72 pode causar DFT e/ou ELA transformou a crença antiga de que os dois distúrbios não tinham relação. Agora é…

consulte Mais informação

O poder da advocacia

The Power of Advocacy images of people who obtained resolutions or proclamations

A AFTD gostaria de destacar o poder da advocacia em contribuir para uma maior conscientização sobre a DFT. A World FTD Awareness Week deste ano foi repleta de contribuições grandes e pequenas de defensores que dedicaram seu tempo para criar eventos de conscientização e arrecadação de fundos, que postaram sobre a DFT e a AFTD nas mídias sociais e que trabalharam com seus legisladores…

consulte Mais informação